Analgesia Nociception Index In Pediatric Patients With Chronic Pain
Launched by MCGILL UNIVERSITY HEALTH CENTRE/RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE ·
Trial Information
Current as of October 15, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at a tool called the Analgesia Nociception Index (ANI) to see if it can help measure how children and teenagers with chronic pain feel after receiving a treatment called an interventional block. The researchers want to understand if changes in the ANI score match up with changes in how sensitive these young patients are to pain. This could help doctors better understand and manage chronic pain in kids aged 9 to 17.
If your child is already getting this type of treatment as part of their usual care for chronic pain, they might be able to take part. During regular clinic visits, the study will record their pain levels and ANI scores without adding extra procedures. This is an observational study, so it doesn’t change the treatment your child is receiving, but it helps gather important information that could improve pain management in the future.
Gender
ALL
Eligibility criteria
About Mcgill University Health Centre/Research Institute Of The Mcgill University Health Centre
The McGill University Health Centre (MUHC) and the Research Institute of the McGill University Health Centre (RI-MUHC) are leading institutions in clinical research and healthcare innovation. With a commitment to advancing medical knowledge and improving patient outcomes, the MUHC integrates cutting-edge research with high-quality patient care. The RI-MUHC fosters a collaborative environment where multidisciplinary teams engage in transformative research across various fields, including oncology, neurology, and cardiovascular health. By leveraging state-of-the-art facilities and a robust network of clinical expertise, both entities strive to translate scientific discoveries into effective treatments, ultimately enhancing the quality of life for patients locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported